Gold prices steady ahead of Fed decision, Trump’s tariff deadline
David P. Hochman, Chief Executive Officer and Chairperson of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), recently acquired 4,000 shares of the company's common stock. The shares were purchased at a weighted average price of $4.66 per share, amounting to a total transaction value of $18,640. The purchase comes as the stock trades near $4.77, down over 50% in the past year. According to InvestingPro analysis, the company maintains impressive gross profit margins of 93%. This purchase increases Hochman's direct ownership to 579,498 shares following the transaction. Additionally, Hochman holds indirect shares through various trusts, including the DPH 2008 Trust and the Solomon Ascher Hochman 2019 Trust, among others. The company, currently valued at $180 million, holds more cash than debt on its balance sheet. InvestingPro subscribers can access 8 additional key insights about OBIO's financial health and growth prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.